Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NCR-300 by Nuwacell Biotechnology for Peritoneal Cancer: Likelihood of Approval
NCR-300 is under clinical development by Nuwacell Biotechnology and currently in Phase I for Peritoneal Cancer. According to GlobalData, Phase...
NCR-300 by Nuwacell Biotechnology for Fallopian Tube Cancer: Likelihood of Approval
NCR-300 is under clinical development by Nuwacell Biotechnology and currently in Phase I for Fallopian Tube Cancer. According to GlobalData,...
NCR-300 by Nuwacell Biotechnology for Endometrial Cancer: Likelihood of Approval
NCR-300 is under clinical development by Nuwacell Biotechnology and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...
NCR-300 by Nuwacell Biotechnology for Ovarian Cancer: Likelihood of Approval
NCR-300 is under clinical development by Nuwacell Biotechnology and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...